单位：人民币元
                                    本报告期末          上年度期末
总资产                        8,075,259,239.82    7,125,598,333.22
所有者权益(或股东权益)        1,684,083,127.43    1,641,417,114.92 
每股净资产                               2.959               2.884
                                 报告期(1-6月)            上年同期
营业总收入                    7,842,986,524.30    6,315,863,054.87
净利润                           45,171,974.33       39,773,494.70 
扣除非经常性损益后的净利润        8,342,756.91       29,075,283.60
基本每股收益                             0.079               0.117
扣除非经常性损益后的基本每股收益         0.015               0.061 
净资产收益率(%)                           2.68                2.46
每股经营活动产生的现金流量净额           0.011               0.306
→查看上海医药详细信息